BL vs SYNA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong gross margins and a history of consistent earnings surprises, the company faces significant headwinds including negative earnings growth, high leverage, and deteriorating profitability. Valuation metrics are stretched relative to fundamentals, with a P/E of 48.25 and a Graham Number of just $11.64, implying the stock is trading at a substantial premium. Persistent insider selling and weak technical sentiment further reinforce caution.
Synaptics (SYNA) presents a stark contrast between poor deterministic health and strong growth valuation. The Piotroski F-Score of 2/9 indicates weak financial health and deteriorating fundamentals, further evidenced by negative profit margins and ROE. However, the company exhibits strong growth momentum with a PEG ratio of 0.51 and a consistent track record of earnings beats over 25 quarters. While liquidity remains robust (Current Ratio 2.93), the combination of insider selling and a weak health score offsets the bullish analyst targets and recent price appreciation.
Compare Another Pair
Related Comparisons
BL vs SYNA: Head-to-Head Comparison
This page compares BlackLine, Inc. (BL) and Synaptics Incorporated (SYNA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.